RAVI RAMSAMOOJ

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology ELIZABETH CITY, NC NPI 1124012406

General Payments — all program years on this page

$3,497.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 187
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $726.52 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $674.2236
Education $52.303

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $620.8433
2019 $794.3144
2020 $227.3612
2021 $227.1412
2022 $481.2326
2023 $419.6321
2024 $726.5239

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086111136 Bayer Healthcare Pharmaceuticals Inc. $16.94 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086177694 Bayer Healthcare Pharmaceuticals Inc. $13.89 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086247132 Bayer Healthcare Pharmaceuticals Inc. $19.41 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086253322 Bayer Healthcare Pharmaceuticals Inc. $13.26 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087339083 Novartis Pharmaceuticals Corporation $19.01 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089472369 Daiichi Sankyo Inc. $22.30 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089472371 Daiichi Sankyo Inc. $26.40 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096692494 Novo Nordisk Inc $16.67 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104314212 AstraZeneca Pharmaceuticals LP $17.95 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104475416 AstraZeneca Pharmaceuticals LP $30.21 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104722595 AstraZeneca Pharmaceuticals LP $14.75 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104769526 AstraZeneca Pharmaceuticals LP $15.61 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105483789 AstraZeneca Pharmaceuticals LP $13.85 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116042874 Amgen Inc. $23.30 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117662153 Amgen Inc. $19.28 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117662155 Amgen Inc. $13.37 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118966581 Otsuka America Pharmaceutical, Inc. $23.00 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118966583 Otsuka America Pharmaceutical, Inc. $24.73 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118966585 Otsuka America Pharmaceutical, Inc. $28.75 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124034349 Vifor Pharma, Inc. $25.58 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124054094 Vifor Pharma, Inc. $16.73 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145124283 Mallinckrodt Hospital Products Inc. $15.70 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145124288 Mallinckrodt Hospital Products Inc. $18.57 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145124292 Mallinckrodt Hospital Products Inc. $21.09 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145830814 AKEBIA THERAPEUTICS INC $17.56 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145832795 AKEBIA THERAPEUTICS INC $24.61 08/08/2024 Education Undisputed 01/23/2026 View at CMS
1145834373 AKEBIA THERAPEUTICS INC $24.61 11/14/2024 Education Undisputed 01/23/2026 View at CMS
1146702740 Ardelyx, Inc. $19.26 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146702742 Ardelyx, Inc. $22.57 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146702744 Ardelyx, Inc. $18.76 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146702746 Ardelyx, Inc. $25.36 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149895825 Travere Therapeutics, Inc. $3.08 04/22/2024 Education Undisputed 01/23/2026 View at CMS
1149895829 Travere Therapeutics, Inc. $4.25 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149895834 Travere Therapeutics, Inc. $12.47 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149895837 Travere Therapeutics, Inc. $17.99 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149895841 Travere Therapeutics, Inc. $24.64 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150690221 Aurinia Pharma U.S., Inc. $13.09 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150690223 Aurinia Pharma U.S., Inc. $13.09 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150690225 Aurinia Pharma U.S., Inc. $14.83 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.